Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience

被引：1
|
作者：
Nguyen, Phillip C. [1 ]
Muirhead, Jenny [1 ]
Tan, Joanne [1 ]
Kalff, Anna [1 ,2 ]
Bergin, Krystal [1 ,2 ]
Walker, Patricia [1 ]
Spencer, Andrew [1 ,2 ]
机构：
[1] Monash Univ, Alfred Hlth, Dept Clin Haematol, Melbourne, Vic, Australia
[2] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2022年 / 52卷 / 07期
关键词：
multiple myeloma; transplant; high risk; allogeneic; CYTOGENETICS; CONSENSUS; IFM99-03; STANDARD; OUTCOMES;
D O I：
10.1111/imj.15842
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The role of upfront non-myeloablative allogeneic stem cell transplantation (NMA alloSCT) in high-risk multiple myeloma (HR-MM) is unclear. We evaluated outcomes of NMA alloSCT following autologous stem cell transplant (ASCT) compared with ASCT alone for newly diagnosed HR-MM. Two-year progression-free survival was improved in the ASCT-NMA alloSCT group (44% vs 16%; P = 0.035), with a trend for improved overall survival (P = 0.118). These results suggest that ASCT-NMA alloSCT can be considered as upfront therapy in HR-MM.
引用
收藏
页码：1263 / 1267
页数：5
相关论文
共 50 条
  • [31] Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
    Karlin, L.
    Arnulf, B.
    Chevret, S.
    Ades, L.
    Robin, M.
    De Latour, R. P.
    Malphettes, M.
    Kabbara, N.
    Asli, B.
    Rocha, V.
    Fermand, J. P.
    Socie, G.
    BONE MARROW TRANSPLANTATION, 2011, 46 (02) : 250 - 256
  • [32] Single vs Tandem Transplant in High-Risk Multiple Myeloma Patients: A Real-Life Single-Centre Analysis
    Manieri, Valentina Maria
    More', Sonia
    Saraceni, Francesco
    Scortechini, Ilaria
    Mancini, Giorgia
    Corvatta, Laura
    Morsia, Erika
    Olivieri, Attilio
    Offidani, Massimo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S235 - S236
  • [33] Impact of bortezomib on outcome of autologous stem cell transplant in multiple myeloma: single-centre analysis
    Anguita Arance, M.
    Gonzalez Sierra, P.
    Almagro Torres, F.
    Martinez Quesada, M. J.
    Lopez Lopez, J. A.
    Duran Nieto, S.
    Alcala Munoz, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S153 - S153
  • [34] Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning
    H Sengeløv
    T A Gerds
    P Brændstrup
    B Kornblit
    B K Mortensen
    S L Petersen
    L L Vindeløv
    Bone Marrow Transplantation, 2013, 48 : 1185 - 1191
  • [35] Outcomes of Single Versus Tandem Hematopoietic Stem Cell Autologous Transplant in High-Risk Myeloma Patients: A Single-Center Experience
    Philip, Shona
    Dehghani, Mina
    Siqueira, Lenicio
    Quint, Anthony
    Lam, Selay
    Phua, Chai Wye
    Xenocostas, Anargyros
    Deotare, Uday
    Louzada, Martha L.
    BLOOD, 2021, 138
  • [36] Autologous stem cell transplantation in myeloma patients - a single-centre experience
    Glavicic, V.
    Tukic, L.
    Tarabar, O.
    Simic, L.
    Stamatovic, D.
    Elez, M.
    Marjanovic, S.
    Glavicic, Bv.
    Madjaru, L.
    Tasic, O.
    Tatomirovic, Z.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S322 - S322
  • [37] Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning
    Sengelov, H.
    Gerds, T. A.
    Braendstrup, P.
    Kornblit, B.
    Mortensen, B. K.
    Petersen, S. L.
    Vindelov, L. L.
    BONE MARROW TRANSPLANTATION, 2013, 48 (09) : 1185 - 1191
  • [38] Allogeneic transplantation after non-myeloablative conditioning consolidation therapy following high-dose melphalan and autologous stem cell transplantation improve outcome in high-risk multiple myeloma
    Martino, M
    Beltrami, G
    Corsetti, MT
    Penna, G
    Messina, G
    Morabito, F
    Iacopino, P
    Carella, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S156 - S156
  • [39] Significant improvement of long-term survival after autologous transplantation in multiple myeloma patients: a single-centre experience
    Krejci, M.
    Hajek, R.
    Adam, Z.
    Krivanova, A.
    Pour, L.
    Havlikova, K.
    Mayer, J.
    Vorlicek, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S441 - S441
  • [40] Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience
    Bryant, Adam
    Pringle, Elizabeth
    Bredeson, Christopher
    Allan, David S.
    Anstee, Grizel
    Bence-Bruckler, Isabelle
    Hamelin, Linda
    Hopkins, Harry Spencer
    Huebsch, Lothar B.
    Sabloff, Mitchell
    Sheppard, Dawn C.
    Tay, Jason
    Atkins, Harold
    BLOOD, 2014, 124 (21)
12345